Evidence map›Paper›PMID 36805566›Full record

ArticleNature metabolism2023

Proteome-wide Mendelian randomization implicates nephronectin as an actionable mediator of the effect of obesity on COVID-19 severity.

Satoshi Yoshiji, Guillaume Butler-Laporte, Tianyuan Lu, Julian Daniel Sunday Willett, Chen-Yang Su, Tomoko Nakanishi, David R Morrison, Yiheng Chen, Kevin Liang, Michael Hultström and 21 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 7 institutions in 6 countries.

Satoshi YoshijiLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.ORCID 0000-0001-8863-2413
Guillaume Butler-LaporteLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.ORCID 0000-0001-5388-0396
Tianyuan LuLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.ORCID 0000-0002-5664-5698
Julian Daniel Sunday WillettLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Chen-Yang SuLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.ORCID 0000-0001-6071-4660
Tomoko NakanishiLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.ORCID 0000-0001-9510-5646
David R MorrisonLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.ORCID 0000-0001-8380-3615
Yiheng ChenLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Kevin LiangLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Michael HultströmLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.ORCID 0000-0003-4675-1099
Yann IlboudoLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Zaman AfrasiabiLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.ORCID 0000-0003-4395-5168
Shanshan LanLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Naomi DugganLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Chantal DeLucaLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Mitra VaeziLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Chris TseliosLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Xiaoqing XueLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Meriem BouabLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Fangyi ShiLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Laetitia LaurentLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Hans Markus MünterMcGill Genome Centre, McGill University, Montréal, Quebec, Canada.ORCID 0000-0002-3165-2840
Marc AfilaloLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Jonathan AfilaloLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Vincent MooserDepartment of Human Genetics, McGill University, Montréal, Quebec, Canada.ORCID 0000-0002-8632-0448
Nicholas J TimpsonMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.ORCID 0000-0002-7141-9189
Hugo ZebergDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Sirui ZhouLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Vincenzo ForgettaLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
Yossi FarjounLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
J Brent RichardsLady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada. brent.richards@mcgill.ca.ORCID 0000-0002-3746-9086
Jewish General Hospital · CAJapan Society for the Promotion of Science · JPMcGill Genome Centre · CAKarolinska Institutet · SEKing's College London · GBUniversity of Bristol · GBUppsala University · SE

Funding

Cancer Research UK C18281/A29019CIHR 100558CIHR 169303CIHR 365825CIHR 409511
6 · The paper itself

Abstract

Obesity is a major risk factor for Coronavirus disease (COVID-19) severity; however, the mechanisms underlying this relationship are not fully understood. As obesity influences the plasma proteome, we sought to identify circulating proteins mediating the effects of obesity on COVID-19 severity in humans. Here, we screened 4,907 plasma proteins to identify proteins influenced by body mass index using Mendelian randomization. This yielded 1,216 proteins, whose effect on COVID-19 severity was assessed, again using Mendelian randomization. We found that an s.d. increase in nephronectin (NPNT) was associated with increased odds of critically ill COVID-19 (OR = 1.71, P = 1.63 × 10

Indexed as

COVID-19ObesityProteomeExtracellular Matrix ProteinsHumansMendelian Randomization AnalysisExtracellular Matrix ProteinsnephronectinProteome

Identifiers

PMID36805566
PMCPMC9940690
OpenAlexW4321369732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.